Alzheimer’s disease is the most common cause of dementia in the elderly (Bear, Conners, & Paradisco, 2007). This is the slow deterioration in memory, thinking and general functionality. It is estimated that 37 million people worldwide live with dementia, affecting 5% of men and 6% of women over 60 years of age (WHO, 2013). Alzheimer’s disease is the most common cause of dementia, with over sixty per cent (60%) dementia cases (WHO, 2013).
Alzheimer’s disease is defined as memory loss with at least one other area of cognitive impairment (e.g., language, attention, orientation, self-monitoring, judgment, motor skill, inability to perform daily activities) (Cheng, Hsieh, Kao, & Chan, 2012) . Memory loss usually begins at about age 65 and slowly progresses to severe impairment over 8 to 10 years.
Our current understanding of the brain aging process has assisted knowledge and treatment of Alzheimer’s disease (Alzhiemers, 2012). Targeting areas in the brain that may be more vulnerable to aging and Alzheimer’s disease, may enhance overall brain function and help slow or stop the natural decline in brain plasticity (Bear et al., 2007).
The neuro-rehabilitation process could have a role with Alzheimer’s disease therapy by boosting the plasticity of the brain (Cheng et al., 2012).
At Brainstorm we have specialised evidence base equipment to assist with the support of the neuro-rehabilitation process. Our trained therapists are skilled with the interpretation and treatment of brain based disorders.
